Erlotinib plus bevacizumab for -mutant advanced non-squamous non-small-cell lung cancer patients: ready for first-line?

Ann Transl Med

Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

Published: December 2019

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976499PMC
http://dx.doi.org/10.21037/atm.2019.09.116DOI Listing

Publication Analysis

Top Keywords

erlotinib bevacizumab
4
bevacizumab -mutant
4
-mutant advanced
4
advanced non-squamous
4
non-squamous non-small-cell
4
non-small-cell lung
4
lung cancer
4
cancer patients
4
patients ready
4
ready first-line?
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!